NCT03770533View on ClinicalTrials.gov

Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using MR-proADM - Pilot Study

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 14, 2018

Primary Completion Date

December 11, 2019

Study Completion Date

December 11, 2019

Conditions
Patients Presenting With Suspicion of Infection to the ED
Interventions
OTHER

MR-proADM guided

MR-proADM value together with routine clinical evaluation identifies patients with a low 14 day mortality risk who do not need to be hospitalized

Trial Locations (4)

28040

Hospital Clínico San Carlos, Madrid

33011

Hospital Universitario Central de Asturias, Oviedo

41009

Hospital Virgen Macarena, Seville

08907

Hospital Universitario de Bellvitge, Barcelona

All Listed Sponsors
lead

Brahms AG

INDUSTRY

NCT03770533 - Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using MR-proADM - Pilot Study | Biotech Hunter | Biotech Hunter